AGP Picks
View all

Science Times Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.

Press releases published on July 29, 2026

Alamar Biosciences 推出 NULISAseq™ Immune 340 Panel 檢測組合,為免疫蛋白質體作全面分析
Office of the Trade Commissioner of Nauru Partners with Dadvan Yousuf to Launch Pacific Digital Assets Forum
Ipsen nominates Catherine Bradley to its Board of Directors as independent Director
Ipsen nomme Catherine Bradley en tant que nouvelle administratrice indépendante au sein de son Conseil d’administration
CorVascular to Showcase DuplexABI™ Solution at SVU 2026 Annual Conference & Marketplace
JASIWAY Expands Its Best-Selling 4-in-1 Sleeper Chair Collection to Meet the Diverse Needs of Modern American Homes
Arradiance Appoints Dr. Jill Becker to Board of Directors
Corporation de Minéraux Stratégiques du Maroc annonce une teneur pouvant atteindre 14,88 % de cuivre et de 696 g/t d’argent à Ouneine, ainsi qu’une teneur pouvant atteindre 4,16 g/t d’or à Aït Zekri
China Leading Medical Catheter OEM Supplier DAXAN: CE MDR, FDA 510(k), and NMPA Registration for Importers
China Leading Closed-System Intermittent Catheter: DAXAN Duro-Pocket® Product Line and OEM ODM Services for Buyers
DAXAN China-Leading Closed-System Catheter Manufacturer: Duro-Pocket® with No-Touch Introducer Tip
China Top Nelaton Hydrophilic Catheter Supplier: DAXAN Straight-Tip Range for Intermittent Catheterization
Custom DuroFlex™ Catheter by DAXAN with Super-Hydrophilic Coating Technology and OEM Support
Wholesale Ready-to-Use Catheter for Urology Distributors: DAXAN Global OEM ODM Services
China Top Urology Catheter Manufacturer DAXAN with ISO 13485 Facility and OEM ODM Services for Distributors
Penn Highlands Healthcare Addresses Workforce Recruitment and Retention Challenges
Bosley and HairClub to Unite Creating North America’s Largest Total Hair Restoration Company
USA-Trained Neurosurgeon Dr. Rao Translates International dAVF Research Into Better Patient Care
EBITDA rebound in H1 2026; execution of the funding plan underway, essential for the Group in H2
Rebond de l’EBITDA au S1 2026 ; réalisation en cours du plan de financement, essentiel pour le Groupe au S2

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Science Times Observer

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.